Real-World Data (RWD) has become one of the most widely discussed topics across the global medtech sector. But what is driving this increased attention? In reality, collecting data from clinicians and ...
For automated capture of end points, aims were to (1) develop and test methods to collect end point–defining image files for patients participating in clinical trials, (2) develop a data model and ...
The US Food and Drug Administration (FDA) is working on ways to facilitate greater use of real-world data (RWD) to help understand the safety and efficacy of medications used during pregnancy and ...
Clayton Irvine, PharmD, MBA, MS, explains that leveraging high-quality, real-world data; cross-institutional collaboration; standardized care pathways; advanced technologies; and integrated ...
Selecting appropriate machine learning (ML) methods for domain-specific tasks remains a persistent challenge, particularly in medicine where datasets are often small, heterogeneous, and incomplete.
On December 15, 2025, the US Food and Drug Administration (FDA) issued a press release announcing that FDA eliminated a major barrier to the use of real-world evidence (RWE) in medical device ...
CAR T-cell therapies are individualized treatments approved for multiple hematologic malignancies, with improved management of adverse effects over time. Access to CAR T-cell therapies is limited by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results